Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 16, 2004 - Issue 11-12
135
Views
47
CrossRef citations to date
0
Altmetric
Research Article

The Biopersistence of Brazilian Chrysotile Asbestos Following Inhalation

, &
Pages 745-761 | Published online: 19 Oct 2008

REFERENCES

  • Atkinson R. J.. 1973. Chrysotile asbestos: Colloidal silica surfaces in acidified suspensions. J. Colloid Interface Sci.. 42: 624–628
  • Agency for Toxic Substances and Disease Registry, 2003; Report on the Expert Panel on Health Effects of Asbestos and Synthetic Vitreous Fibers: The Influence of fiber length. Atlanta, GA, Prepared for Agency for Toxic Substances and Disease Registry, Division of Health Assessment and Consultation
  • Bellmann B., Muhle H., Creutzenberg O., Ernst H., Muller M., Bernstein D. M., Riego Sintes J. M.. 2003. Calibration study on subchronic inhalation toxicity of man-made vitreous fibers in rats. Inhal. Toxicol.. 15(12)1147–1177. [PUBMED], [INFOTRIEVE]
  • Berman D. W., Crump K. S., Chatfield E. J., Davis J. M., Jones A. D.. 1995. The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal.. 15(2)181–195. [PUBMED], [INFOTRIEVE]
  • Berman D. W., Crump K. S.. 2004; Technical support document for a protocol to assess asbestos-related risk. Washington, DC, Office of Solid Waste and Emergency Response, U.S. Environmental Protection Agency
  • Bernstein D. M., Chevalier J., Smith P.. 2003a. Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure. Inhal. Toxicol.. 15(14)1387–1419. [PUBMED], [INFOTRIEVE]
  • Bernstein D. M., Mast R., Anderson R., Hesterberg T. W., Musselman R., Kamstrup O., Hadley J.. 1994. An experimental approach to the evaluation of the biopersistence of respirable synthetic fibers and minerals. Environ. Health Perspect.. 102(Suppl. 5)15–18. [PUBMED], [INFOTRIEVE]
  • Bernstein D. M., Riego Sintes J. M., Ersboell B. K., Kunert J.. 2001a. Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal. Toxicol.. 13(10)823–849. [PUBMED], [INFOTRIEVE]
  • Bernstein D. M., Riego Sintes J. M., Ersboell B. K., Kunert J.. 2001b. Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumor response in rats. Inhal. Toxicol.. 13(10)851–875. [PUBMED], [INFOTRIEVE]
  • Bernstein D. M., Riego-Sintes J. M. R.. 1999; Methods for the determination of the hazardous properties for human health of man made mineral fibers (MMMF), Vol. EUR 18748 EN, April. 93. http://ecb.ei.jrc.it/DOCUMENTS/Testing-Methods/mmmfweb.pdf, European Commission Joint Research Centre, Institute for Health and Consumer Protection, Unit, Toxicology and Chemical Substances, European Chemicals Bureau.
  • Bernstein D. M., Rogers R., Smith P.. 2003b. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal. Toxicol.. 15(13)1247–1274. [PUBMED], [INFOTRIEVE]
  • Bernstein D. M., Rogers R., Smith P.. 2004. The biopersistence of Canadian chrysotile asbestos following inhalation: Final results through 1 year after cessation of exposure. Inhal. Toxicol., In press.
  • Bolton R. E., Vincent J. H., Jones A. D., Addison J., Beckett S. T.. 1983. An overload hypothesis for pulmonary clearance of UICC amosite fibres inhaled by rats. Br. J. Ind. Med.. 40: 264–272. [PUBMED], [INFOTRIEVE]
  • Brismar H., Patwardhan A., G., Jaremko, Nyengaard J.. 1996. Thickness estimation of fluorescent sections using a CLSM. J. Microsc.. 184(2)106–116
  • Cannon W. C., Blanton E. F., McDonald K. E.. 1983. The flow-past chamber: An improved nose-only exposure system for rodents. Am. Ind. Hyg. Assoc. J.. 44(12)923–928. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Cossette M., Delvaux P.. 1979. Technical evaluation of chrysotile asbestos ore bodies, In. Short course in mineralogical techniques of asbestos determination, R. C., Ledoux. Mineralogical Association of Canada, TorontoCanada, pp.79–109, May.
  • Cruxên Barros, de, Oliveira M.. 1989; Mineralogical analysis chrysotile, tech rep 36 889. CEP 01064–970 São Paulo. Brazil, IPT, Instituto de Pesquisas Tecnológicas
  • Davis J. M., Addison J., Bolton R. E., Donaldson K., Jones A. D., Smith T.. 1986. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br. J. Exp. Pathol.. 67(3)415–430. [PUBMED], [INFOTRIEVE]
  • EPA, 2003. Report on the Peer Consultation Workshop to discuss a proposed protocol to assess asbestos-related risk. Prepared for U.S. Environmental Protection Agency. Office of Solid Waste and Emergency Response, Washington, DC 20460, EPA Contract No, 68-C-98–148, Work Assignment 2003–05. Prepared by Eastern Research Group, Inc., 110 Hartwell Avenue, Lexington, MA 02421. Final Report May 30, 2003.
  • Etherington D. J., Pugh D., Silver I. A.. 1981. Collagen degradation in an experimental inflammatory lesion: Studies on the role of the macrophage. Acta Biol. Med. Ger.. 40(10–11)1625–1636. [PUBMED], [INFOTRIEVE]
  • Hargreaves A., Taylor W. H.. 1946. An x-ray examination of decomposition products of chrysotile (asbestos) and serpentine. Mineral. Mag.. 27: 204–216
  • Hesterberg T. W., Chase G., Axten C., Miller W. C., Musselman R. P., Kamstrup O., Hadley J., Morscheidt C., Bernstein D. M., Thevenaz P.. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol. Appl. Pharmacol.. 151(2)262–275. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Hodgson A. A.. 1979. Chemistry and physics of asbestos, In. Asbestos: Properties, applications and hazards, L. M., Chissick, S. S., Chissick, pp. 80–81, New York, John Wiley & Sons
  • Hodgson J. T., Darnton A.. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann. Occup. Hyg.. 44(8)565–601. [CROSSREF]
  • Ilgren, E, Chatfield E.. 1997. Coalinga fibre—A short, amphibole-free chrysotile. Evidence for lack of fibrogenic activity. Indoor Built Environ.. 6: 264–276
  • Ilgren E., Chatfield E.. 1998. Coalinga fibre—A short, amphibole-free chrysotile part 2: Evidence for lack of tumourigenic activity. Indoor Built Environ.. 7: 18–31
  • Ilgren E., Chatfield E.. 1998b. Coalinga fibre: A short, amphibole-free chrysotile, part 3: Lack of biopersistence. Indoor Built Environ.. 7: 98–109
  • Kamstrup O., Davis J. M., Ellehauge A., Guldberg M.. 1998. The biopersistence and pathogenicity of man-made vitreous fibres after short- and long-term inhalation. Ann. Occup. Hyg.. 42(3)191–199. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Kiyohara P. K.. 1991; Estudo da interface crisotila-cimento Portland em compósitos de fibro-cimento por métodos óptico-eletrônicos, Tese de Doutorado, apres. São Paulo, EPUSP
  • Mattson, St., M.. 1994. Glass fibres in simulated lung fluid: Dissolution behavior and analytical requirements. Ann. Occup. Hyg.. 38: 857–877
  • McDonald J. C., McDonald A. D.. 1997. Chrysotile, tremolite and carcinogenicity. Ann. Occup. Hyg.. 41(6)699–705. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Morrow P. E.. 1988. Possible mechanisms to explain dust overloading of the lungs. Fundam. Appl. Toxicol.. 10(3)369–384. [PUBMED], [INFOTRIEVE]
  • Muhle H., Pott F., Bellmann B., Takenaka S., Ziem U.. 1987. Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann. Occup. Hyg.. 31(4B)755–764. [PUBMED], [INFOTRIEVE]
  • Nagy B., Bates T. F.. 1952. Stability of chrysotile asbestos. Am. Mineral.. 37: 1055–1058
  • Oberdorster G.. 1995. Lung particle overload: implications for occupational exposures to particles. Regul. Toxicol. Pharmacol.. 21(1)123–135. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Pott F., Ziem U., Reiffer F. J., Huth F., Ernst H., Mohr U.. 1987. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp. Pathol.. 32(3)129–152. [PUBMED], [INFOTRIEVE]
  • Raabe O. G., Yeh H. C., Newton G. J., Phalen R. F., Velasquez D. J.. 1977. Deposition of inhaled monodisperse aerosols in small rodents, In. Inhaled particles, IV. W. H., Walton, Proceedings of an international symposium organized by the British Occupational Hygiene Society, Edinburgh. 22–26 September 1975; vol. 1: pp. 3–21, Oxford, Pergamon Press
  • Rittinghausen S., Ernst H., Muhle H., Mohr U.. 1992. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Exp. Toxicol. Pathol.. 44(1)55–58. [PUBMED], [INFOTRIEVE]
  • Rogers R. A., Antonini J. M., Brismar H., Lai J., Hesterberg T. W., Oldmixon E. H., Thevenaz P., Brain J. D.. 1999. In situ microscopic analysis of asbestos and synthetic vitreous fibers retained in hamster lungs following inhalation. Environ. Health Perspect.. 107(5)367–375. [PUBMED], [INFOTRIEVE]
  • Skinner H. C. W., Ross M., Frondel C., 1988; Asbestos and Other Fibrous minerals. Oxford University Press
  • Smith R. W.. 1973; Aqueous Surface Chemistry of Asbestos Minerals. National Inst. for Occupational Safety and Health, Cincinnati, OH, (Code: HEWOSH), Report number: PHS-OH-00332, NTIs Number: PB90–100942INZ. April.
  • Speil S., Leineweber J. P.. 1969. Asbestos minerals in modern technology. Environ. Research. 2: 166–208
  • Stoeber W., Flachsbart H., Hochrainer D.. 1970. Der Aerodynamische Durchmesser von Latexaggregaten und Asbestfassern. Staub-Reinh. Luft.. 30: 277–285
  • Wagner J. C., Berry G., Skidmore J. W., Pooley F. D.. 1980. The comparative effects of three chrysotiles by injection and inhalation in rats. IARC Sci. Publ. 30: 363–372. [PUBMED], [INFOTRIEVE]
  • Weibel E. R.. 1984; The pathway for oxygen. Cambridge, MA, Harvard University Press
  • World Health Organization, 1985; Reference methods for measuring airborne man-made mineral fibres (MMMF), WHO/EURO MMMF reference scheme, WHO EURO Technical Committee for Monitoring and Evaluating Airborne MMMF, Vol. EH-4. Copenhagen, WHO

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.